Sg Americas Securities, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$24.1 Billion
Q2 2025

A detailed history of Sg Americas Securities, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,282 shares of CRNX stock, worth $577,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,282

Previous 522,266 96.12%

Holding current value

$577,631

Previous $17.5 Million 96.67%

% of portfolio

0.0%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$25.56 - $33.76 $12.8 Million - $16.9 Million	-501,984 Reduced 96.12%	20,282 $583,000
Q1 2025 Apr 15, 2025	SELL	$32.3 - $53.15 $651,814 - $1.07 Million	-20,180 Reduced 3.72%	522,266 $17.5 Million
Q4 2024 Jan 17, 2025	BUY	$50.66 - $60.69 $26.8 Million - $32.1 Million	529,483 Added 4084.57%	542,446 $27.7 Million
Q3 2024 Oct 03, 2024	SELL	$43.83 - $54.98 $2.9 Million - $3.63 Million	-66,088 Reduced 83.6%	12,963 $662,000
Q2 2024 Jul 12, 2024	BUY	$42.12 - $51.91 $3.08 Million - $3.79 Million	73,084 Added 1224.8%	79,051 $3.54 Million
Q1 2024 May 06, 2024	BUY	$34.76 - $46.81 $207,412 - $279,315	5,967 New	5,967 $279,000
Q1 2023 Apr 28, 2023	BUY	$15.31 - $21.1 $251,068 - $346,018	16,399 Added 167.9%	26,166 $420,000
Q4 2022 Feb 02, 2023	SELL	$15.49 - $19.05 $86,108 - $105,898	-5,559 Reduced 36.27%	9,767 $179,000
Q3 2022 Oct 31, 2022	SELL	$18.11 - $22.37 $182,295 - $225,176	-10,066 Reduced 39.64%	15,326 $301,000
Q2 2022 Jul 29, 2022	BUY	$16.49 - $27.64 $418,714 - $701,834	25,392 New	25,392 $474,000
Q1 2022 Apr 29, 2022	SELL	$17.15 - $28.31 $109,176 - $180,221	-6,366 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$19.35 - $28.41 $249,634 - $366,517	-12,901 Reduced 66.96%	6,366 $181,000
Q3 2021 Nov 01, 2021	BUY	$16.88 - $25.23 $325,226 - $486,106	19,267 New	19,267 $406,000
Q3 2020 Nov 09, 2020	SELL	$13.62 - $17.66 $201,603 - $261,403	-14,802 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$13.04 - $23.23 $193,018 - $343,850	14,802 New	14,802 $259,000

Others Institutions Holding CRNX

# of Institutions

232

Shares Held

90M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $1.53B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Crinetics Pharmaceuticals, Inc. Transaction History